165 related articles for article (PubMed ID: 37271822)
1. Clinical significance of immunohistochemical expression of DDR1 and β-catenin in colorectal carcinoma.
Dawoud MM; Salah M; Mohamed ASED
World J Surg Oncol; 2023 Jun; 21(1):168. PubMed ID: 37271822
[TBL] [Abstract][Full Text] [Related]
2. Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.
Youssef NS; Osman WM
Int J Clin Exp Pathol; 2015; 8(2):1503-14. PubMed ID: 25973035
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of SALL4 and β-catenin in colorectal cancer.
Hao L; Zhao Y; Wang Z; Yin H; Zhang X; He T; Song S; Sun S; Wang B; Li Z; Su Q
J Mol Histol; 2016 Apr; 47(2):117-28. PubMed ID: 26779651
[TBL] [Abstract][Full Text] [Related]
6. The Expression of Stem Cell Marker LGR5 and Its Coexpression with Β-Catenin in Sporadic Colorectal Carcinoma and Adenoma: A Comparative Immunohistochemical Study.
Ahmed EM; Farag AS; Abdelwahed MS; Hanbazazh M; Samman A; Ashmawy D; Abd-Elhameed NR; Tharwat M; Othman AE; Shawky TA; Attia RM; Ibrahim AA; Azzam S; Elhussiny MEA; Nasr M; Naeem SA; Abd-Elhay WM; Ali Alfaifi AM; Hasan A
Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37512045
[No Abstract] [Full Text] [Related]
7. [The significance of beta-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma].
Duan GJ; Yan XC; Bian XW; Li J; Chen X
Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):518-22. PubMed ID: 15634446
[TBL] [Abstract][Full Text] [Related]
8. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
[TBL] [Abstract][Full Text] [Related]
9. [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].
Ou Y; Jing G; Liu J; Gao S; Cheng Z; Dong X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Aug; 32(4):854-61. PubMed ID: 26710459
[TBL] [Abstract][Full Text] [Related]
10. Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
Hur H; Ham IH; Lee D; Jin H; Aguilera KY; Oh HJ; Han SU; Kwon JE; Kim YB; Ding K; Brekken RA
BMC Cancer; 2017 Jan; 17(1):87. PubMed ID: 28143619
[TBL] [Abstract][Full Text] [Related]
11. The destruction complex of beta-catenin in colorectal carcinoma and colonic adenoma.
Bourroul GM; Fragoso HJ; Gomes JW; Bourroul VS; Oshima CT; Gomes TS; Saba GT; Palma RT; Waisberg J
Einstein (Sao Paulo); 2016; 14(2):135-42. PubMed ID: 27462886
[TBL] [Abstract][Full Text] [Related]
12. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302
[No Abstract] [Full Text] [Related]
13. Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.
Sherif MF; Ismail IM; Ata SMS
Ann Diagn Pathol; 2020 Dec; 49():151621. PubMed ID: 32949893
[TBL] [Abstract][Full Text] [Related]
14. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas.
Yang SH; Baek HA; Lee HJ; Park HS; Jang KY; Kang MJ; Lee DG; Lee YC; Moon WS; Chung MJ
Oncol Rep; 2010 Aug; 24(2):311-9. PubMed ID: 20596615
[TBL] [Abstract][Full Text] [Related]
15. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong.
Wong SC; Lo ES; Chan AK; Lee KC; Hsiao WL
Mol Pathol; 2003 Dec; 56(6):347-52. PubMed ID: 14645698
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.
Jeitany M; Leroy C; Tosti P; Lafitte M; Le Guet J; Simon V; Bonenfant D; Robert B; Grillet F; Mollevi C; El Messaoudi S; Otandault A; Canterel-Thouennon L; Busson M; Thierry AR; Martineau P; Pannequin J; Roche S; Sirvent A
EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29438985
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.
Wong SC; Lo ES; Lee KC; Chan JK; Hsiao WL
Clin Cancer Res; 2004 Feb; 10(4):1401-8. PubMed ID: 14977843
[TBL] [Abstract][Full Text] [Related]
18. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.
Pan Y; Han M; Zhang X; He Y; Yuan C; Xiong Y; Li X; Zeng C; Lu K; Zhu H; Lu X; Liu Q; Liang H; Liao Z; Ding Z; Zhang Z; Chen X; Zhang W; Zhang B
Cell Oncol (Dordr); 2022 Feb; 45(1):163-178. PubMed ID: 35089546
[TBL] [Abstract][Full Text] [Related]
19. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.
Baldus SE; Mönig SP; Huxel S; Landsberg S; Hanisch FG; Engelmann K; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Clin Cancer Res; 2004 Apr; 10(8):2790-6. PubMed ID: 15102686
[TBL] [Abstract][Full Text] [Related]
20. Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1): A Novel Predictor for Recurrence of Hepatocellular Carcinoma After Curative Resection.
Xu M; Cui C
Med Sci Monit; 2021 Nov; 27():e933109. PubMed ID: 34815375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
